tiprankstipranks
Advertisement
Advertisement

Polymarket Earnings: Will UNH, MSCI, IBKR Beat Earnings Tomorrow?

Polymarket Earnings: Will UNH, MSCI, IBKR Beat Earnings Tomorrow?

On Tuesday, April 21, UnitedHealth Group (UNH), MSCI (MSCI), and Interactive Brokers (IBKR) will report their earnings. UnitedHealth and MSCI will report before the market open, while Interactive Brokers’ results will come after the close. Traders are already weighing in with their expectations on Polymarket.

Claim 30% Off TipRanks

Wall Street’s Earnings Estimates

  • UnitedHealth is expected to report an adjusted EPS of $6.67.
  • MSCI is expected to report an adjusted EPS of $4.44.
  • Interactive Brokers is expected to report an adjusted EPS of 60 cents.

What is Polymarket?

Polymarket is a prediction platform where traders bet on the outcomes of real-world events, including earnings reports, elections, and economic indicators. Polymarket odds reflect expectations and can provide insight into investor sentiment.

Will UnitedHealth Beat Earnings?

UnitedHealth has beaten or met earnings estimates during 17 of the past 18 quarters for a success rate of 94.45%. Polymarket gives the healthcare company a 59% chance of beating its estimated adjusted EPS of $6.67.

Will MSCI Beat Earnings?

MSCI has beaten or met earnings estimates during 18 of the past 18 quarters for a success rate of 100%. Polymarket gives the financial data and technology company a 97% chance of beating its estimated adjusted EPS of $4.44.

Will Interactive Brokers Beat Earnings?

Interactive Brokers has beaten or met earnings estimates during 12 of the past 18 quarters for a success rate of 66.67%. Polymarket traders give the trading platform a 96% chance of surpassing its estimated adjusted EPS of 60 cents.

Disclosure: Polymarket odds reflect expectations, not guaranteed outcomes. The odds represent the views and expectations of traders, but actual earnings results can differ significantly from these predictions. Investors should treat Polymarket data as just one tool when evaluating their investment decisions.

Disclaimer & DisclosureReport an Issue

1